Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent structure
Reexamination Certificate
2000-06-30
2003-06-03
Willse, David H. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent structure
C623S001220
Reexamination Certificate
active
06572648
ABSTRACT:
BACKGROUND OF THE INVENTION
The present invention provides devices and methods for the endoluminal placement of prostheses, particularly within the vascular system for the treatment of cardiovascular disease, such as vascular stenoses, dissections and other tissue separation conditions, aneurysms, and the like. The apparatus and methods, however, are also useful for placement in other body lumens, such as the ureter, urethra, biliary tract, gastrointestinal tract and the like, for the treatment of other conditions which may benefit from the introduction of a reinforcing or protective structure within the body lumen. The prostheses will be placed endoluminally. As used herein, “endoluminally” will mean placement by percutaneous or cutdown procedures, wherein the prosthesis is transluminally advanced through the body lumen from a remote location to a target site in the lumen. In vascular procedures, the prostheses will typically be introduced “endovascularly” using a catheter over a guidewire under fluoroscopic guidance. The catheters and guidewires may be introduced through conventional access sites to the vascular system, such as through the femoral artery, or brachial and subclavian arteries, for access to the target site.
An endoluminal prosthesis typically comprises at least one radially expansible, usually cylindrical, body segment. By “radially expansible,” it is meant that the body segment can be converted from a small diameter configuration (used for endoluminal placement) to a radially expanded, usually cylindrical, configuration which is achieved when the prosthesis is implanted at the desired target site. The prosthesis may be non-resilient, e.g., malleable, thus requiring the application of an internal force to expand it at the target site. Typically, the expansive force can be provided by a balloon catheter, such as an angioplasty balloon for vascular procedures. Alternatively, the prosthesis can be self-expanding. Such self-expanding structures may be provided by a temperature-sensitive superelastic material, such as Nitinol, which naturally assumes a radially expanded condition once an appropriate temperature has been reached. The appropriate temperature can be, for example, a temperature slightly below normal body temperature; if the appropriate temperature is above normal body temperature, some method of heating the structure must be used. Another type of self-expanding structure uses resilient material, such as a stainless steel or superelastic alloy, and forming the body segment so that it possesses its desired, radially-expanded diameter when it is unconstrained, e.g., released from radially constraining forces of a sheath. To remain anchored in the body lumen, the prosthesis will remain partially constrained by the lumen. The self-expanding prosthesis can be delivered in its radially constrained configuration, e.g. by placing the prosthesis within a delivery sheath or tube and retracting the sheath at the target site. Such general aspects of construction and delivery modalities are well-known in the art.
The dimensions of a typical endoluminal prosthesis will depend on its intended use. Typically, the prosthesis will have a length in the range from 0.5 cm to 10 cm, usually being from about 0.8 cm to 5 cm, for vascular applications. The small (radially collapsed) diameter of cylindrical prostheses will usually be in the range from about 1 mm to 10 mm, more usually being in the range from 1.5 mm to 6 mm for vascular applications. The expanded diameter will usually be in the range from about 2 mm to 50 mm, preferably being in the range from about 25 mm to 45 mm for aortic applications.
One type of endoluminal prosthesis includes both a stent component and a graft component. These endoluminal prostheses are often called stent grafts. A stent graft is typically introduced using a catheter with both the stent and graft in contracted, reduced-diameter states. Once at the target site, the stent and graft are expanded. After expansion, the catheter is withdrawn from the vessel leaving the stent graft at the target site. Grafts may be made of, for example, PTFE, ePTFE or Dacron® polyester.
Grafts are used within the body for various reasons, such as to repair damaged or diseased portions of blood vessels such as may be caused by injury, disease, or an aneurysm. It has been found effective to introduce pores into the walls of the graft to provide ingrowth of tissue onto the walls of the graft. With larger diameter grafts, woven graft material is often used. In small and large diameter vessels, porous fluoropolymers, such as ePTFE, have been found useful.
Coil-type stents can be wound about the catheter shaft in torqued compression for deployment. The coil-type stent can be maintained in this torqued compression condition by securing the ends of the coil-type stent in position on a catheter shaft. The ends are released by, for example, pulling on wires once at the target site. See, for example, U.S. Pat. Nos. 5,372,600 and 5,476,505. Alternatively, the endoluminal prosthesis can be maintained in its reduced-diameter condition by a sleeve; the sleeve can be selectively retracted to release the prosthesis. A third approach is the most common. A balloon is used to expand the prosthesis at the target site. The stent is typically extended past its elastic limit so that it remains in its expanded state after the balloon is deflated and removed. One balloon expandable stent is the Palmaz-Schatz stent available from the Cordis Division of Johnson & Johnson. Stents are also available from Medtronic AVE of Santa Rosa, Calif. and Guidant Corporation of Indianapolis, Indiana.
SUMMARY OF THE INVENTION
The present invention is directed to an endoluminal prosthesis and a method for treating a dissection, as well as other tissue separation conditions, within blood vessels and other tubular body structures, using an endoluminal prosthesis.
A first aspect of the invention is directed to an endoluminal prosthesis which includes a coiled body and a graft material covering at least part of the coiled body to create a coiled stent graft. The average stent graft diameter to turns-width ratio may be about 0.8 to 1 to about 2.4 to 1 when expanded. The average turns-width to stent graft length ratio, when expanded, may be about 1 to 1 to about 1 to 4. Adjacent turns of the stent graft may lie adjacent to, or may be spaced apart from, one another when in the radially expanded condition.
Another aspect of the invention is directed to a method for treating a tissue separation, such as a vascular dissection, within a tubular body structure. The tissue separation condition comprises separated tissue defining a gap between the separated tissue and the remainder of the tubular body structure. The method includes placing an endoluminal prosthesis in a radially contracted condition at a target site, the endoluminal prosthesis comprising a coiled body with a graft material covering at least part of the coiled body to create a coiled stent graft. The stent graft is expanded to a radially expanded condition thereby pressing the separated tissue against the remainder of the tubular body structure.
REFERENCES:
patent: 4553545 (1985-11-01), Maass et al.
patent: 4760849 (1988-08-01), Kropf
patent: 4795458 (1989-01-01), Regan
patent: 4886062 (1989-12-01), Wiktor
patent: 4913141 (1990-04-01), Hillstead
patent: 5037427 (1991-08-01), Harada et al.
patent: 5133732 (1992-07-01), Wiktor
patent: 5147370 (1992-09-01), McNamara et al.
patent: 5282823 (1994-02-01), Schwartz et al.
patent: 5607445 (1997-03-01), Summers
patent: 5772668 (1998-06-01), Summers et al.
patent: 5824052 (1998-10-01), Khosravi et al.
patent: 5824053 (1998-10-01), Khosravi et al.
patent: 5833699 (1998-11-01), Chuter
patent: 6019779 (2000-02-01), Thorud et al.
patent: 6027516 (2000-02-01), Kolobow et al.
patent: 6090134 (2000-07-01), Tu et al.
patent: 6364904 (2002-04-01), Smith
patent: 2002/0004679 (2002-01-01), Eury et al.
patent: 297 21 310 (1998-02-01), None
patent: 2 671 482 (1992-07-01), None
patent: 2 270 264 (1994-03-01), None
D. Maass, C
Fogarty Thomas J.
Hill Bradley B.
Kamdar Kirti P.
Klumb Katherine J.
Blanco Javier G.
Hann James F.
Haynes Beffel & Wolfeld LLP
Vascular Architects, Inc.
Willse David H.
LandOfFree
Endoluminal prosthesis and tissue separation condition... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endoluminal prosthesis and tissue separation condition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endoluminal prosthesis and tissue separation condition... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3112763